SeqOnce Biosciences is a privately held company located in Carlsbad, California. Our core competencies, including enzymology, nucleic acid chemistry, sample processing and manufacturing, have served as engines for innovation, development of intellectual property, and ongoing product development.
SeqOnce Biosciences was formed in 2014 by Joseph Dunham, Ph.D, a researcher at the University of Southern California and Chris Angermayer, a former portfolio manager and investment analyst. The founders are dedicated to building a team of individuals who are leaders in the industry, thereby enabling SeqOnce to become a preeminent player in the NGS sample preparation market.
Company Details
- Employees
- 9
- Founded
- 2014
- Address
- 1926 Kellogg Ave, Carlsbad,california 92008,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.seqonce.com
- HQ
- Carlsbad, California
Seqonce Biosciences Inc. Questions
Seqonce Biosciences Inc.'s website is http://www.seqonce.com
Seqonce Biosciences Inc.'s LinkedIn profile is https://www.linkedin.com/company/seqonce-biosciences
Seqonce Biosciences Inc. has
9 employees.
View email and phone details for 9
employees at Seqonce Biosciences Inc..
Seqonce Biosciences Inc.'s industry is
Biotechnology Research
Seqonce Biosciences Inc.'s top competitors are
Saqana,
Blazedx,
Jefferies,
Merso Labs,
Plasmid Bioscience,
Wedbush,
Appia Bio,
Biolexis Therapeutics, Inc.,
Amgen,
Singular Genomics.
Seqonce Biosciences Inc.'s categories are Biotechnology Research
Seqonce Biosciences Inc.'s founding year is 2014
